Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes

Byeong Woo Park, Seho Park, Hyung Seok Park, Ja Seung Koo, Woo Ick Yang, Jun Sang Lee, Hyewon Hwang, Seung Il Kim, Kyong Sik Lee

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

In order to investigate the implications of cyclooxygenase-2 (COX-2) expression in combination with Ki-67 on breast cancer outcomes, the COX-2 and Ki-67 expression levels and other clinicopathologic parameters were investigated in 861 breast cancers. Clini-copathological parameters and survival were investigated in association with the expression levels of both COX-2 and Ki-67 using univariate and multivariate analyses. COX-2 expression was positive in 493 (57.3%) of invasive tumors. COX-2 was associated with favorable markers, but was not related to survival outcome by itself. However, COX-2 in proliferative tumors [COX-2(+)/Ki-67(+)] were significantly associated with unfavorable factors and the worst survival, but COX-2 in non-proliferative tumors [COX-2(+)/Ki-67(-)] showed significantly favorable parameters and better outcomes. COX-2(-)/Ki-67(any) showed intermediate prognosis. The statistical significance was maintained in stage-matched and multivariate analyses. The results of present study suggest that COX-2 expression is a common event in breast cancers and may play in a different ways by the proliferation status of the tumor cells. Further studies should be carried out to verify the role of COX-2 by proliferative conditions of breast tumor cells.

Original languageEnglish
Pages (from-to)741-751
Number of pages11
JournalBreast Cancer Research and Treatment
Volume133
Issue number2
DOIs
Publication statusPublished - 2012 Jun 1

Fingerprint

Cyclooxygenase 2
Breast Neoplasms
Neoplasms
Multivariate Analysis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Park, Byeong Woo ; Park, Seho ; Park, Hyung Seok ; Koo, Ja Seung ; Yang, Woo Ick ; Lee, Jun Sang ; Hwang, Hyewon ; Kim, Seung Il ; Lee, Kyong Sik. / Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes. In: Breast Cancer Research and Treatment. 2012 ; Vol. 133, No. 2. pp. 741-751.
@article{efe88039e2bb4e27a62767fd8037122f,
title = "Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes",
abstract = "In order to investigate the implications of cyclooxygenase-2 (COX-2) expression in combination with Ki-67 on breast cancer outcomes, the COX-2 and Ki-67 expression levels and other clinicopathologic parameters were investigated in 861 breast cancers. Clini-copathological parameters and survival were investigated in association with the expression levels of both COX-2 and Ki-67 using univariate and multivariate analyses. COX-2 expression was positive in 493 (57.3{\%}) of invasive tumors. COX-2 was associated with favorable markers, but was not related to survival outcome by itself. However, COX-2 in proliferative tumors [COX-2(+)/Ki-67(+)] were significantly associated with unfavorable factors and the worst survival, but COX-2 in non-proliferative tumors [COX-2(+)/Ki-67(-)] showed significantly favorable parameters and better outcomes. COX-2(-)/Ki-67(any) showed intermediate prognosis. The statistical significance was maintained in stage-matched and multivariate analyses. The results of present study suggest that COX-2 expression is a common event in breast cancers and may play in a different ways by the proliferation status of the tumor cells. Further studies should be carried out to verify the role of COX-2 by proliferative conditions of breast tumor cells.",
author = "Park, {Byeong Woo} and Seho Park and Park, {Hyung Seok} and Koo, {Ja Seung} and Yang, {Woo Ick} and Lee, {Jun Sang} and Hyewon Hwang and Kim, {Seung Il} and Lee, {Kyong Sik}",
year = "2012",
month = "6",
day = "1",
doi = "10.1007/s10549-012-1971-2",
language = "English",
volume = "133",
pages = "741--751",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes. / Park, Byeong Woo; Park, Seho; Park, Hyung Seok; Koo, Ja Seung; Yang, Woo Ick; Lee, Jun Sang; Hwang, Hyewon; Kim, Seung Il; Lee, Kyong Sik.

In: Breast Cancer Research and Treatment, Vol. 133, No. 2, 01.06.2012, p. 741-751.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes

AU - Park, Byeong Woo

AU - Park, Seho

AU - Park, Hyung Seok

AU - Koo, Ja Seung

AU - Yang, Woo Ick

AU - Lee, Jun Sang

AU - Hwang, Hyewon

AU - Kim, Seung Il

AU - Lee, Kyong Sik

PY - 2012/6/1

Y1 - 2012/6/1

N2 - In order to investigate the implications of cyclooxygenase-2 (COX-2) expression in combination with Ki-67 on breast cancer outcomes, the COX-2 and Ki-67 expression levels and other clinicopathologic parameters were investigated in 861 breast cancers. Clini-copathological parameters and survival were investigated in association with the expression levels of both COX-2 and Ki-67 using univariate and multivariate analyses. COX-2 expression was positive in 493 (57.3%) of invasive tumors. COX-2 was associated with favorable markers, but was not related to survival outcome by itself. However, COX-2 in proliferative tumors [COX-2(+)/Ki-67(+)] were significantly associated with unfavorable factors and the worst survival, but COX-2 in non-proliferative tumors [COX-2(+)/Ki-67(-)] showed significantly favorable parameters and better outcomes. COX-2(-)/Ki-67(any) showed intermediate prognosis. The statistical significance was maintained in stage-matched and multivariate analyses. The results of present study suggest that COX-2 expression is a common event in breast cancers and may play in a different ways by the proliferation status of the tumor cells. Further studies should be carried out to verify the role of COX-2 by proliferative conditions of breast tumor cells.

AB - In order to investigate the implications of cyclooxygenase-2 (COX-2) expression in combination with Ki-67 on breast cancer outcomes, the COX-2 and Ki-67 expression levels and other clinicopathologic parameters were investigated in 861 breast cancers. Clini-copathological parameters and survival were investigated in association with the expression levels of both COX-2 and Ki-67 using univariate and multivariate analyses. COX-2 expression was positive in 493 (57.3%) of invasive tumors. COX-2 was associated with favorable markers, but was not related to survival outcome by itself. However, COX-2 in proliferative tumors [COX-2(+)/Ki-67(+)] were significantly associated with unfavorable factors and the worst survival, but COX-2 in non-proliferative tumors [COX-2(+)/Ki-67(-)] showed significantly favorable parameters and better outcomes. COX-2(-)/Ki-67(any) showed intermediate prognosis. The statistical significance was maintained in stage-matched and multivariate analyses. The results of present study suggest that COX-2 expression is a common event in breast cancers and may play in a different ways by the proliferation status of the tumor cells. Further studies should be carried out to verify the role of COX-2 by proliferative conditions of breast tumor cells.

UR - http://www.scopus.com/inward/record.url?scp=84863717156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863717156&partnerID=8YFLogxK

U2 - 10.1007/s10549-012-1971-2

DO - 10.1007/s10549-012-1971-2

M3 - Article

C2 - 22286316

AN - SCOPUS:84863717156

VL - 133

SP - 741

EP - 751

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -